Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Drug Discovery Automation: High-content Screening & Cell Based Assays

Jan de Sonneville's Biography



Jan de Sonneville, CEO, Life Science Methods B.V.

Born on 14-09-1980 in Amsterdam, the Netherlands. Bachelor in Electrical Engineering, Delft University of Technology (TUDelft), Master in NanoScience (Applied Physics), given as joint program by TUDelft and Leiden University, the Netherlands (2006). PhD on the development of four novel research methods for Cell Biology, thesis title: “Reinventing microinjection, new microfluidic methods for cell biology” (2011). Founded Life Science Methods BV to sell Automated Microinjection Systems for high throughput screening using cell spheroids and zebrafish embryos (2011).

Jan de Sonneville Image

Automated Microinjection of Cell-polymer Suspensions in 3D ECM Scaffolds for High-throughput Quantitative Cancer Invasion Screens

Thursday, 6 June 2013 at 15:00

Add to Calendar ▼2013-06-06 15:00:002013-06-06 16:00:00Europe/LondonAutomated Microinjection of Cell-polymer Suspensions in 3D ECM Scaffolds for High-throughput Quantitative Cancer Invasion Screens SELECTBIOenquiries@selectbiosciences.com

Automated microinjection of cancer cells in collagen gel allows for instant 3D cell spheroid formation. Subsequent RNA-i screening is used to discover targets affecting cell migration and survival. Example: prostate cancer; a new kinase inhibitor shows the translational power in 3D cells spheroids, zebrafish, mice and human tissue.


Add to Calendar ▼2013-06-06 00:00:002013-06-07 00:00:00Europe/LondonDrug Discovery Automation: High-content Screening and Cell Based AssaysSELECTBIOenquiries@selectbiosciences.com